Advertisement

Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases

      Ovarian stimulation and cryopreservation of fertilized oocytes before cancer therapy is the best established and efficient fertility preservation technique and should still be considered before chemotherapy. Within a short time frame of 2 weeks, between 8.6 (18–25 y) and 5.1 (36–40 y) fertilized oocytes can be cryopreserved.

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jemal A.
        • Clegg L.X.
        • Ward E.
        • Ries L.A.
        • Wu X.
        • Jamison P.M.
        • et al.
        Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.
        Cancer. 2004; 101: 3-27
        • Behringer K.
        • Breuer K.
        • Reineke T.
        • May M.
        • Nogova L.
        • Klimm B.
        • et al.
        German Hodgkin's Lymphoma Study Group. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
        J Clin Oncol. 2005; 23: 7555-7564
        • Walshe J.M.
        • Denduluri N.
        • Swain S.
        Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
        J Clin Oncol. 2006; 24: 5769-5779
        • Bines J.
        • Oleske D.M.
        • Cobleigh M.A.
        Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
        J Clin Oncol. 1996; 14: 1718-1729
        • Beck-Fruchter R.
        • Weiss A.
        • Shalec E.
        GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data.
        Hum Reprod Update. 2008; 14: 553-561
        • Blumenfeld Z.
        • von Wolff M.
        GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
        Hum Reprod Update. 2008; 14: 543-552
        • Badawy A.
        • Elnashar A.
        • El-Ashry M.
        • Shahat M.
        Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
        Fertil Steril. 2009; 91: 694-697
        • Oktay K.
        • Karlikaya G.
        Ovarian function after transplantation of frozen, banked autologous ovarian tissue.
        N Engl J Med. 2000; 342: 1919
        • Lee S.J.
        • Schover L.
        • Partridge A.H.
        • Patrizio P.
        • Wallace W.
        • Hegerty R.
        • et al.
        American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.
        J Clin Oncol. 2006; 24: 2917-2931
        • Huober-Zeeb C.
        • Lawrenz B.
        • Popovici R.M.
        • Strowitzki T.
        • Germeyer A.
        • Stute P.
        • von Wolff M.
        Improving fertility preservation in cancer: Ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined.
        Fertil Steril. 2010; (DOI:)
        • Martin J.R.
        • Kodaman P.
        • Oktay K.
        • Taylor H.
        Ovarian cryopreservation with transposition of a contralateral ovary: a combined approach for fertility preservation in women receiving pelvic radiation.
        Fertil Steril. 2007; 87 (189.e5–e7)
        • Von Wolff M.
        • Strowitzki T.
        • van der Ven H.
        • Montag M.
        In vitro maturation is an efficient technique to generate oocytes and should be considered in combination with cryopreservation of ovarian tissue for preservation of fertility in women.
        J Clin Oncol. 2006; 20: 5336-5337
      1. FertiPROTEKT. Network for fertility preservation before chemo- and radiotherapy. Available at http://www.fertiprotekt.eu. Accessed November 13, 2009.

      2. German national IVF registry. Annual report 2008, page 19. Available at:http://www.deutsches-ivf-register.de. Last Accessed July 21, 2010.

      3. Swiss national IVF registry. Annual report 2008, page 17. Available at: http://www.sgrm.org/wb/pages/fivnat-kommission/statistiken_reports.php. Last accessed July 21, 2010.

        • Oktay K.
        • Sahin G.
        • Ucar K.F.
        • Barad D.
        • Blanchette H.
        • Gleicher N.
        Fertility preservation is an emerging discipline extending beyond cancer patients: analysis of a large experience.
        Fertil Steril. 2008; (O–141): S51
        • Klock S.C.
        • Zhang J.X.
        • Kazer R.
        Fertility preservation for female cancer patients: early clinical experience.
        Fertil Steril. 2010; 94: 149-155
        • Quintero R.B.
        • Helmer A.
        • Murray E.
        • Westphal L.M.
        Fertility preservation in female cancer patients.
        Fertil Steril. 2005; 84 (O–170)
        • Quintero R.B.
        • Helmer A.
        • Huang J.Q.
        • Westphal L.M.
        Ovarian stimulation for fertility preservation in patients with cancer.
        Fertil Steril. 2010; 93: 865-868